Skip to main content

Rubinstein Julie's Form 4 filing

Adaptive Biotechnologies Corp (ADPT) · filed Mar 5, 2026

Accession no.
0001780664-26-000002
Filed
Mar 5, 2026
Trade date
Mar 3-5, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 10 non-derivative transactions and 6 derivative transactions. Open-market sales total $1.49M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rubinstein JulieCIK 0001780664Officer (President and COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 3, 2026Common StockMOption exerciseAcquired+14,722$6.55+$96,429.1602,971Direct
Mar 3, 2026Common StockMOption exerciseAcquired+11,881$12.14+$144,235.34614,852Direct
Mar 3, 2026Common StockSSaleDisposed−24,423$15.49−$378,312.27590,429Direct
Mar 3, 2026Common StockSSaleDisposed−6,518$16.33−$106,438.94583,911Direct
Mar 4, 2026Common StockMOption exerciseAcquired+14,722$6.55+$96,429.1598,633Direct
Mar 4, 2026Common StockMOption exerciseAcquired+11,881$12.14+$144,235.34610,514Direct
Mar 4, 2026Common StockSSaleDisposed−30,941$16.60−$513,620.6579,573Direct
Mar 5, 2026Common StockMOption exerciseAcquired+14,722$6.55+$96,429.1594,295Direct
Mar 5, 2026Common StockMOption exerciseAcquired+11,881$12.14+$144,235.34606,176Direct
Mar 5, 2026Common StockSSaleDisposed−30,941$16.00−$495,056575,235Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 3, 2026Common StockMOption exerciseDisposed−14,722$0.00$0180,603Direct
Mar 3, 2026Common StockMOption exerciseDisposed−11,881$0.00$0451,463Direct
Mar 4, 2026Common StockMOption exerciseDisposed−14,722$0.00$0165,881Direct
Mar 4, 2026Common StockMOption exerciseDisposed−11,881$0.00$0439,582Direct
Mar 5, 2026Common StockMOption exerciseDisposed−14,722$0.00$0151,159Direct
Mar 5, 2026Common StockMOption exerciseDisposed−11,881$0.00$0427,701Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)